JP Morgan Chase
SGFY

JP Morgan Chase’s Signify Health, Inc. SGFY Stock Holding History

JP Morgan Chase’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,130,569
Closed -$61.1M – 7454
2022
Q4 		$61.1M Buy
2,130,569
+1,382,277
+185% +$39.9M 0.01% 1011
2022
Q3 		$21.8M Buy
748,292
+732,995
+4,792% +$16.9M ﹤0.01% 1518
2022
Q2 		$211K Buy
15,297
+840
+6% +$11.8K ﹤0.01% 5056
2022
Q1 		$263K Buy
14,457
+674
+5% +$9.66K ﹤0.01% 5046
2021
Q4 		$196K Sell
13,783
-192,290
-93% -$2.98M ﹤0.01% 5372
2021
Q3 		$3.68M Buy
206,073
+194,802
+1,728% +$5.01M ﹤0.01% 3299
2021
Q2 		$343K Sell
11,271
-1,070,270
-99% -$29.4M ﹤0.01% 4939
2021
Q1 		$31.6M Buy
+1,081,541
New +$33.5M ﹤0.01% 1410

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

JP Morgan Chase's SGFY Position: Q1 2023 in Review

JP Morgan Chase sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 2,130,569 shares — an estimated $61.1M sold.

JP Morgan Chase first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $61.1M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • JP Morgan Chase reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 2,130,569 Signify Health, Inc. shares in Q1 2023, an estimated $61.1M.
  • JP Morgan Chase first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • JP Morgan Chase's Signify Health, Inc. position peaked at $61.1M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.